Silvercrest Asset Management’s Pulmonx LUNG Stock Holding History

Silvercrest Asset Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13K	Buy	+10,000	New	+$13.8K	﹤0.01%	843
2026 Q1	–	Sell	-1,264,233	Closed	-$2.79M	–	869
2025 Q4	$2.79M	Hold	1,264,233	–	–	0.02%	496
2025 Q3	$2.05M	Buy	1,264,233 +333,676	+36%	+$698K	0.01%	534
2025 Q2	$2.41M	Hold	930,557	–	–	0.02%	525
2025 Q1	$6.26M	Buy	+930,557	New	+$6.59M	0.04%	376

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Silvercrest Asset Management's LUNG Position: Q2 2026 in Review

Silvercrest Asset Management opened a new position in Pulmonx (LUNG) in Q2 2026: 10,000 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #843 among its holdings. This is a return to the name: Silvercrest Asset Management previously reported a position in LUNG as recently as Q4 2025.

Silvercrest Asset Management first reported a position in LUNG in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.26M in Q1 2025. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Silvercrest Asset Management held 10,000 shares of Pulmonx worth $13K as of Q2 2026.
Pulmonx was a new Silvercrest Asset Management position in Q2 2026.
Pulmonx made up ﹤0.01% of Silvercrest Asset Management's portfolio in Q2 2026, its #843 holding.
Silvercrest Asset Management first reported a position in Pulmonx in Q1 2025 and has held it in 5 quarters since.
Silvercrest Asset Management's Pulmonx position peaked at $6.26M in Q1 2025.
107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.